This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Pharmaceutical marketers today have their work cut out for them. On the one hand, technological developments like digital healthcare, personalized medicine, and artificial intelligence are reshaping how consumers take care of their health.
But 2024 will bring even more drastic change in this area, as Google finally deprecates third-party cookies in Chrome after numerous delays. For healthcare and pharmaceutical advertisers, this shift adds yet another layer of targeting and measurement complexity to an industry that is already wrought with privacy-related regulations.
In addition to adapting to these factors specific to the healthcare industry, advertisers in the space are making substantial changes to meet the demands of the digital advertising world, including Google’s long-delayed deprecation of third-party cookies in Chrome in the second half of 2024. Certainly not!
Healthcare and pharmaceutical advertisers such as Gilead Sciences are injecting more and more of their media budgets into the creator economy. Now, despite uncertainty over the future of TikTok, industry experts say that influencer marketing has matured enough that healthcare clients are embracing it.
that delivers privacy-first machine learning-based advertising solutions to drive measurable outcomes for healthcare marketers, today announced the launch of AdTheorent Health Predictive Audiences. AdTheorent Health, a division of AdTheorent Holding Company, Inc. Key benefits of AdTheorent Health Audiences: Highly customizable.
With cookie deprecation finally here, how could it not be? Everything from creating addressable audiences for pharmaceutical and healthcare companies to measuring the ad’s effectiveness will become more difficult in 2024 without consumer consent.
We organize all of the trending information in your field so you don't have to. Join 5,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content